Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy
S Balagholi, R Dabbaghi, P Eshghi, SA Mousavi… - … and Apheresis Science, 2020 - Elsevier
Therapeutic plasmapheresis (TP) is the process of the separation and removal of plasma
from other blood components and is considered as an adjunctive treatment strategy to the …
from other blood components and is considered as an adjunctive treatment strategy to the …
COVID-19 and therapeutic Apheresis
S Tselmin, U Julius, N Jarzebska… - Hormone and …, 2022 - thieme-connect.com
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, is an unprecedented challenge
for the global community. The pathogenesis of COVID-19, its complications and long term …
for the global community. The pathogenesis of COVID-19, its complications and long term …
Efficacy of therapeutic plasma exchange alone or in combination with ruxolitinib for the treatment of Penn Class 3 and 4 cytokine release syndrome complicating …
WL Gluck, WM Smith, SP Callahan… - Journal of Cellular …, 2021 - scientificarchives.com
This study was conducted to validate the efficacy of therapeutic plasma exchange (TPE) in
reducing the excessive cytokine load complicating a subset of patients with severe COVID …
reducing the excessive cytokine load complicating a subset of patients with severe COVID …